Explore About Kintor & Its Products
Kintor is a biopharmaceutical company that focuses on the development and commercialization of innovative antibody drugs. Their products aim to treat various diseases including cancer and autoimmune disorders.
Kintor was founded in 2009.
The company is headquartered in Suzhou, China.
The founders of Kintor are not publicly known.
In 2016, Kintor received IND approval from the China Food and Drug Administration for their first clinical trial drug, Proxalutamide, for the treatment of prostate cancer.
In 2020, Kintor received emergency use authorization from the Chinese government for the use of Proxalutamide in the treatment of COVID-19.
Kintor is actively involved in research and development collaborations with academic institutions and other pharmaceutical companies to expand their product pipeline.
Brands Similar to Kintor
BeiGene is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative cancer treatments.
Innovent Biologics is a biopharmaceutical company that develops and commercializes high-quality biologic medicines for the treatment of cancer and autoimmune diseases.
Jiangsu Hengrui Medicine is a leading biopharmaceutical company in China, focusing on research, development, manufacturing, and marketing of innovative medications for cancer and other diseases.
Top Trending & High Rated Products of Kintor
Proxalutamide
Proxalutamide is an investigational drug developed by Kintor for the treatment of prostate cancer. It has also shown potential in the treatment of COVID-19.
GT20029
GT20029 is another investigational drug being developed by Kintor, targeting androgen receptor-related diseases, such as breast cancer and liver cancer.
Common Questions Asked by Customers About Kintor & Its Products
What are the therapeutic areas of focus for Kintor?
Kintor is focused on developing drugs for the treatment of cancer and autoimmune disorders.
What is Proxalutamide?
Proxalutamide is an investigational drug developed by Kintor for the treatment of prostate cancer. It has also shown potential in the treatment of COVID-19.
Where is Kintor headquartered?
Kintor is headquartered in Suzhou, China.
What is the history of Kintor?
Kintor was founded in 2009 and has since focused on the development and commercialization of innovative antibody drugs.
Who are the competitors of Kintor?
Some of the competitors of Kintor include BeiGene, Innovent Biologics, and Jiangsu Hengrui Medicine.
![Dualcomm10/100/1000Base-T Gigabit Ethernet Network TAP [ETAP-2003]](https://m.media-amazon.com/images/I/71PCWZwmvyL._AC_SX569_.jpg)
